Dawn phenomenon in Type 1 (insulin-depen
β
B. Beaufrère; M. Beylot; C. Metz; A. Ruitton; R. François; J. P. Riou; R. Mornex
π
Article
π
1988
π
Springer
π
English
β 580 KB
In order to reassess the role of growth hormone in the dawn phenomenon, we studied eight C-peptide negative diabetic adolescents, who are likely to exhibit important nocturnal growth hormone surges. The insulin infusion rate necessary to maintain euglycaemia was predetermined in each patient from 22